Annual Shareholders Equity
$21.17 M
-$15.71 M-42.60%
31 December 2023
Summary:
ClearPoint Neuro annual stockholders equity is currently $21.17 million, with the most recent change of -$15.71 million (-42.60%) on 31 December 2023. During the last 3 years, it has risen by +$18.80 million (+790.74%). CLPT annual shareholders equity is now -56.60% below its all-time high of $48.79 million, reached on 31 December 2021.CLPT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$29.00 M
-$3.13 M-9.74%
30 September 2024
Summary:
ClearPoint Neuro quarterly stockholders equity is currently $29.00 million, with the most recent change of -$3.13 million (-9.74%) on 30 September 2024. Over the past year, it has increased by +$4.91 million (+20.37%). CLPT quarterly shareholders equity is now -40.56% below its all-time high of $48.79 million, reached on 31 December 2021.CLPT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLPT Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -42.6% | +20.4% |
3 y3 years | +790.7% | -34.3% |
5 y5 years | +1301.3% | +382.7% |
CLPT Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -56.6% | +790.7% | -40.6% | +37.0% |
5 y | 5 years | -56.6% | +1301.3% | -40.6% | >+9999.0% |
alltime | all time | -56.6% | +196.9% | -40.6% | +232.8% |
ClearPoint Neuro Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $29.00 M(-9.7%) |
June 2024 | - | $32.13 M(-7.1%) |
Mar 2024 | - | $34.58 M(+63.3%) |
Dec 2023 | $21.17 M(-42.6%) | $21.17 M(-12.1%) |
Sept 2023 | - | $24.09 M(-12.1%) |
June 2023 | - | $27.41 M(-15.9%) |
Mar 2023 | - | $32.58 M(-11.7%) |
Dec 2022 | $36.89 M(-24.4%) | $36.89 M(-7.5%) |
Sept 2022 | - | $39.88 M(-6.9%) |
June 2022 | - | $42.82 M(-6.4%) |
Mar 2022 | - | $45.73 M(-6.3%) |
Dec 2021 | $48.79 M(+1952.5%) | $48.79 M(+10.6%) |
Sept 2021 | - | $44.12 M(-8.0%) |
June 2021 | - | $47.97 M(+9.1%) |
Mar 2021 | - | $43.98 M(+1750.3%) |
Dec 2020 | $2.38 M(-48.2%) | $2.38 M(+1494.2%) |
Sept 2020 | - | $149.10 K(-88.9%) |
June 2020 | - | $1.34 M(-51.5%) |
Mar 2020 | - | $2.76 M(-39.8%) |
Dec 2019 | $4.59 M(+203.5%) | $4.59 M(-23.7%) |
Sept 2019 | - | $6.01 M(-13.0%) |
June 2019 | - | $6.91 M(+1460.6%) |
Mar 2019 | - | $442.60 K(-70.7%) |
Dec 2018 | $1.51 M | $1.51 M(-39.4%) |
Sept 2018 | - | $2.49 M(-30.0%) |
Date | Annual | Quarterly |
---|---|---|
June 2018 | - | $3.56 M(-25.1%) |
Mar 2018 | - | $4.75 M(-18.5%) |
Dec 2017 | $5.83 M(-870.9%) | $5.83 M(-19.9%) |
Sept 2017 | - | $7.28 M(-14.6%) |
June 2017 | - | $8.53 M(-486.8%) |
Mar 2017 | - | -$2.20 M(+191.6%) |
Dec 2016 | -$756.10 K(-61.8%) | -$756.10 K(-231.6%) |
Sept 2016 | - | $574.60 K(-114.5%) |
June 2016 | - | -$3.96 M(+9.7%) |
Mar 2016 | - | -$3.61 M(+82.4%) |
Dec 2015 | -$1.98 M(+1875.2%) | -$1.98 M(-66.0%) |
Sept 2015 | - | -$5.82 M(-1.0%) |
June 2015 | - | -$5.88 M(+62.0%) |
Mar 2015 | - | -$3.63 M(+3519.2%) |
Dec 2014 | -$100.30 K(-98.5%) | -$100.30 K(-98.7%) |
Sept 2014 | - | -$7.93 M(+75.8%) |
June 2014 | - | -$4.51 M(+43.7%) |
Mar 2014 | - | -$3.14 M(-54.1%) |
Dec 2013 | -$6.83 M(-13.1%) | -$6.83 M(+21.8%) |
Sept 2013 | - | -$5.61 M(+99.1%) |
June 2013 | - | -$2.82 M(+53.9%) |
Mar 2013 | - | -$1.83 M(-76.7%) |
Dec 2012 | -$7.87 M(-64.0%) | -$7.87 M(+36.1%) |
Sept 2012 | - | -$5.78 M(-46.2%) |
June 2012 | - | -$10.73 M(-50.9%) |
Dec 2011 | -$21.84 M | -$21.84 M |
FAQ
- What is ClearPoint Neuro annual stockholders equity?
- What is the all time high annual shareholders equity for ClearPoint Neuro?
- What is ClearPoint Neuro annual shareholders equity year-on-year change?
- What is ClearPoint Neuro quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ClearPoint Neuro?
- What is ClearPoint Neuro quarterly shareholders equity year-on-year change?
What is ClearPoint Neuro annual stockholders equity?
The current annual shareholders equity of CLPT is $21.17 M
What is the all time high annual shareholders equity for ClearPoint Neuro?
ClearPoint Neuro all-time high annual stockholders equity is $48.79 M
What is ClearPoint Neuro annual shareholders equity year-on-year change?
Over the past year, CLPT annual stockholders equity has changed by -$15.71 M (-42.60%)
What is ClearPoint Neuro quarterly stockholders equity?
The current quarterly shareholders equity of CLPT is $29.00 M
What is the all time high quarterly shareholders equity for ClearPoint Neuro?
ClearPoint Neuro all-time high quarterly stockholders equity is $48.79 M
What is ClearPoint Neuro quarterly shareholders equity year-on-year change?
Over the past year, CLPT quarterly stockholders equity has changed by +$4.91 M (+20.37%)